Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.7K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do We Really Care About Our Children's School Safety? The Proof Is in the Pudding.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same author

Can You Properly Manage Delusional Parasitosis?

Innovations in clinical neuroscience·2025
Same author

Resurgence of polio and the path to eradication.

Tropical medicine & international health : TM & IH·2025
Same author

Babesiosis - An Unseen Epidemic.

WMJ : official publication of the State Medical Society of Wisconsin·2025
Same author

When Suicidality Is Suspected.

Southern medical journal·2025
Same author

Firearm Shootings: A Serious Public Health Issue.

Southern medical journal·2025

Related Experiment Video

Updated: Mar 12, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K

Deep Brain Stimulation for Treatment-Refractory Depression.

Puneet Narang1, Amber Retzlaff1, Kanwarjeet Brar1

  • 1From the University of Minnesota Regions Hospital, Minneapolis-St Paul, the University of Minnesota Medical School, Minneapolis-St Paul, and the University of Louisville School of Medicine, Louisville, Kentucky.

Southern Medical Journal
|November 5, 2016
PubMed
Summary

Deep brain stimulation (DBS) shows potential for treatment-resistant depression, with 40-70% long-term response rates. However, more rigorous research is needed to confirm efficacy and understand its mechanisms.

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.6K
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.9K

Related Experiment Videos

Last Updated: Mar 12, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.6K
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.9K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Neurosurgery

Background:

  • Depression affects many, with over a third experiencing treatment-resistant forms.
  • Deep brain stimulation (DBS) is an experimental intervention for refractory depression.

Purpose of the Study:

  • To review the literature on DBS for treatment-refractory depression from 2010-2015.
  • To assess the efficacy and limitations of DBS in this patient population.

Main Methods:

  • Literature review of English-language studies published between 2010 and 2015.
  • Analysis of studies investigating deep brain stimulation for treatment-resistant depression.

Main Results:

  • Most studies were open-label, lacking large randomized controlled trials.
  • Long-term response rates ranged from 40% to 70%, influenced by electrode placement.
  • Effects lasted from months to years, but DBS remains invasive and costly.

Conclusions:

  • DBS is a potentially efficacious and safe option for treatment-resistant depression.
  • Further research with rigorous design, clear criteria, and consistent measures is essential.
  • Understanding the neurobiology and predictive biomarkers for DBS response requires further investigation.